Form4insider filings, from the source

SEC Form 4 · accession 0001181431-15-003279

Sagent Pharmaceuticals, Inc. · SGNT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Feb 21, 2015
Accepted (ET)
Feb 24, 2015 · 6:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001369786

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockFeb 21, 2015M760$0.00A8,686D
Common StockFeb 22, 2015M567$0.00A9,253D
Common StockF2holding———2,000ISee Footnote
Common StockF3holding———433,770ISee Footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF4,F5—Feb 21, 2015M760D——Common Stock7601,520D
Restricted Stock UnitsF4,F6—Feb 22, 2015M567D——Common Stock567567D

Explanation of responses